List of Excipients in API phentermine and topiramate extended-release
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing phentermine and topiramate extended-release
Detailed excipient profiles for phentermine and topiramate extended-release
Excipient focus: CELLULOSE, MICROCRYSTALLINE
phentermine and topiramate extended-release drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | phentermine and topiramate extended-release | 43598-624 |
| >Company | >Ingredient | >NDC |
phentermine and topiramate extended-release drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSE
phentermine and topiramate extended-release drug variants containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | phentermine and topiramate extended-release | 43598-624 |
| >Company | >Ingredient | >NDC |
phentermine and topiramate extended-release drug variants not containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
phentermine and topiramate extended-release drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | phentermine and topiramate extended-release | 43598-624 |
| >Company | >Ingredient | >NDC |
phentermine and topiramate extended-release drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
phentermine and topiramate extended-release drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | phentermine and topiramate extended-release | 43598-624 |
| >Company | >Ingredient | >NDC |
phentermine and topiramate extended-release drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2208
phentermine and topiramate extended-release drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | phentermine and topiramate extended-release | 43598-624 |
| >Company | >Ingredient | >NDC |
phentermine and topiramate extended-release drug variants not containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
phentermine and topiramate extended-release drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | phentermine and topiramate extended-release | 43598-624 |
| >Company | >Ingredient | >NDC |
phentermine and topiramate extended-release drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
phentermine and topiramate extended-release drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | phentermine and topiramate extended-release | 43598-624 |
| >Company | >Ingredient | >NDC |
phentermine and topiramate extended-release drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
